首页|益气固肺祛风方联合布地奈德治疗小儿变应性鼻炎临床疗效观察

益气固肺祛风方联合布地奈德治疗小儿变应性鼻炎临床疗效观察

扫码查看
目的 探讨益气固肺祛风方联合布地奈德治疗小儿变应性鼻炎(AR)的疗效及对患儿免疫功能的影响.方法 选取 2022 年 8 月~2023 年 3 月在郑州市第九人民医院治疗的 112 例 AR 患儿作为研究对象,随机分为观察组和对照组,每组各 56 例.对照组使用布地奈德治疗,观察组使用益气固肺祛风方+布地奈德治疗,比较两组患儿的临床疗效、中医证候积分、免疫因子水平、炎性因子水平以及复发率.结果 治疗后,观察组总有效率高于对照组(94.64%vs 78.57%,P<0.05);两组中医证候积分总分与治疗前比较均降低,且观察组比对照组降低幅度更大(P<0.05);两组 CD3+、CD4+水平及CD3+/CD4+与治疗前比较均升高,且观察组比对照组升高更明显(P<0.05);两组白细胞介素-2(IL-2)、γ干扰素(IFN-γ)水平与治疗前比较均升高、白细胞介素-4(IL-4)水平均降低,且观察组变化更明显(P<0.05).随访 2 个月,观察组复发率低于对照组(16.07%vs 32.14%,P<0.05).结论 小儿 AR给予益气固肺祛风方联合布地奈德治疗较单独给予布地奈德治疗,可以明显提高疗效及免疫功能,降低复发率,值得临床推广应用.
Observation on the clinical effect of Yiqi Gufei Qufeng decoction combined with budesonide in the treat-ment of pediatric allergic rhinitis
Objective To explore the curative effect of Yiqi Gufei Qufeng decoction combined with budesonide in the treatment of pediatric allergic rhinitis(AR)and its impact on immune function of children.Methods A total of 112 AR children treated in Zhengzhou Ninth People's Hospital from August 2022 to March 2023 were selected as the research subjects and randomly divided into the obser-vation group and the control group,with 56 cases in each group.The control group was treated with budesonide,while the observation group was treated with Yiqi Gufei Qufeng decoction combined with budesonide.The clinical curative effect,TCM syndrome score,immune factor level,inflammatory factor level and recurrence rate were compared between the two groups.Results After treatment,the effective rate of the observation group was higher than that of the control group(94.64%vs 78.57%,P<0.05).The total scores of TCM syndrome in both groups were lower than those before treatment,and the decrease in the observation group was greater than that in the control group(P<0.05).The levels of CD3+,CD4+ and CD3+/CD4+ in both groups were higher than those before treatment,and the increase in the observation group was more significant than that in the control group(P<0.05).The levels of interleukin-2(IL-2)and interferon-γ(IFN-γ)in both groups were higher than those before treatment,while the levels of interleukin-4(IL-4)were lower,and the changes in the ob-servation group were more obvious(P<0.05).After 2 months of follow-up,the recurrence rate in the observation group was lower than that in the control group(16.07%vs 32.14%,P<0.05).Conclu-sion Compared with budesonide alone,the combination of Yiqi Gufei Qufeng decoction and budes-onide in the treatment of pediatric AR can significantly improve the curative effect and immune func-tion,and reduce the recurrence rate,which is worthy of clinical promotion and application.

BudesonideYiqi Gufei Qufeng decoctionAllergic rhinitis in children

王楠、王改丽、柴亚斐、陈团营

展开 >

郑州市第九人民医院儿科 河南郑州 450000

布地奈德 益气固肺祛风方 小儿变应性鼻炎

河南省中医药科学研究专项

2019ZY2042

2024

华北理工大学学报(医学版)
河北联合大学

华北理工大学学报(医学版)

影响因子:0.569
ISSN:2095-2694
年,卷(期):2024.26(2)
  • 15